Response: Sensitization initiated
Year: 2009
Type: article
Abstract: In their letter to the editor, Heuser et al showed that acute myelogenous leukemia (AML) cells are mobilized into the peripheral blood using the CXCR4 inhibitor AMD3100 (Plerixafor; Genzyme Inc).[1][1] Interestingly, they further studied the effect of this agent on the mobilization of leukemia stem
Source: Blood
Authors: Abdel Kareem Azab, Irene M. Ghobrial
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2025174169